VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,058,430 | -25.5% | 558,837 | 0.0% | 0.19% | -26.2% |
| Q4 2022 | $10,813,496 | -43.7% | 558,837 | 0.0% | 0.26% | -47.6% |
| Q3 2022 | $19,196,000 | +149.2% | 558,837 | +10.9% | 0.50% | +121.4% |
| Q2 2022 | $7,702,000 | -33.0% | 504,037 | 0.0% | 0.22% | -22.8% |
| Q1 2022 | $11,502,000 | -65.5% | 504,037 | -44.2% | 0.29% | -62.3% |
| Q4 2021 | $33,291,000 | -26.4% | 902,926 | -6.2% | 0.77% | -19.1% |
| Q3 2021 | $45,253,000 | -22.0% | 962,826 | 0.0% | 0.95% | -17.1% |
| Q2 2021 | $58,011,000 | – | 962,826 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |